Phase 4 Irritable Bowel Syndrome Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with Irritable Bowel Syndrome (IBS) using a standard set of diagnostic guidelines called the Rome IV criteria
- You are 18 years of age or older (any gender can apply)
- You have any type of IBS, whether it mainly causes diarrhea, constipation, or a mix of both
Who may not be able to join:
- You have concerning symptoms such as unexplained weight loss, anemia, symptoms that wake you at night, a lump in your abdomen, or a strong family history of cancer
- You have taken antibiotics in the past month
- You have certain medical conditions where taking probiotics would not be safe, such as a severe infection throughout the body (severe sepsis) or if you are pregnant
- You have been diagnosed with a cancerous growth in your bowel
- You have had a bowel infection diagnosed within the past month
- You have had surgery on your abdomen at any point in the past
- You have a significant mental health condition such as schizophrenia or bipolar disorder with manic episodes
- You have a known allergy to probiotics
- You have taken any probiotic supplements within the past month
- You have previously used the specific probiotic called Skal Pro™ (LP299V™)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yeong Yeh Lee, MD, PhD, Hospital Universiti Sains Malaysia
Phone: +60122888024
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Improving the severity of symptoms in individuals with IBS, assessed by IBS Symptom Severity Scale (IBSSSS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.